Tag: FDA inspections
23
MayChinese Generic Production: Manufacturing and Quality Concerns
China supplies 80% of global API, raising quality and supply chain concerns. Explore FDA inspection gaps, purity issues, and the push for diversification in 2026.
2
FebruaryQuality concerns: when clinicians question generic manufacturing
Clinicians are raising alarms about the quality of generic drugs made overseas, especially in India and China. Studies show higher rates of adverse events, supply chain risks, and inspection gaps-raising urgent questions about safety, transparency, and the future of affordable medicine.
Recent posts
-
12 Oct 2025
Daclatasvir and Hepatitis C: A Guide for Long-Term Survivors
-
1 Dec 2025
Cost Barriers to Medication Adherence and How to Get Help
-
30 Dec 2025
NSAIDs vs. Acetaminophen: Which Pain Reliever Is Right for You?
-
2 Feb 2026
Quality concerns: when clinicians question generic manufacturing
-
4 Dec 2025
Rheumatoid Arthritis Medications: How DMARDs and Biologics Interact in Treatment